Caviglia, G.P.; Abate, M.L.; Rolle, E.; Carucci, P.; Armandi, A.; Rosso, C.; Olivero, A.; Ribaldone, D.G.; Tandoi, F.; Saracco, G.M.;
et al. The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma. Biology 2021, 10, 215.
https://doi.org/10.3390/biology10030215
AMA Style
Caviglia GP, Abate ML, Rolle E, Carucci P, Armandi A, Rosso C, Olivero A, Ribaldone DG, Tandoi F, Saracco GM,
et al. The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma. Biology. 2021; 10(3):215.
https://doi.org/10.3390/biology10030215
Chicago/Turabian Style
Caviglia, Gian Paolo, Maria Lorena Abate, Emanuela Rolle, Patrizia Carucci, Angelo Armandi, Chiara Rosso, Antonella Olivero, Davide Giuseppe Ribaldone, Francesco Tandoi, Giorgio Maria Saracco,
and et al. 2021. "The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma" Biology 10, no. 3: 215.
https://doi.org/10.3390/biology10030215
APA Style
Caviglia, G. P., Abate, M. L., Rolle, E., Carucci, P., Armandi, A., Rosso, C., Olivero, A., Ribaldone, D. G., Tandoi, F., Saracco, G. M., Ciancio, A., Bugianesi, E., & Gaia, S.
(2021). The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma. Biology, 10(3), 215.
https://doi.org/10.3390/biology10030215
